| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash provided by financing activities | 1,865,702 | 846,367 |
| Net change in cash and cash equivalents | 892,428 | 112,198 |
| Cash and cash equivalents at beginning of period | 673,264 | - |
| Cash and cash equivalents at end of period | 1,565,692 | - |
Kraig Biocraft Laboratories, Inc. (KBLB)
Kraig Biocraft Laboratories, Inc. (KBLB)